Ongoing clinical trials of coronavirus disease 2019 (COVID-19) vaccines on children
| Vaccine | BNT162b2 | mRNA-1273 | AZD1222 | Ad26.COV2.S |
|---|---|---|---|---|
| Manufacturer | Pfizer BioNTech | Moderna | Oxford AstraZeneca | Janssen (J&J) |
| Ongoing/completed clinical trials on children | ∙ Phase 3 (finished): adolescents 12 to 15 y | ∙ Phase 2/3 (2021.2~): adolescents 12 to 17 y | ∙ Phase 2 (2021.02~): Children ≥6 y | ∙ Phase 2a: Adolescents 12 to 17 y |
| ∙ Phase 1/2/3 (2021.3~):6 mo to 11 y | ∙ Phase 2/3 (2021.3~): 6 mo to 11 y |
Adapted from the article of Kang et al. (Clin Exp Pediatr 2021; 64: 328-38).20)